Provider Specialty and the Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Older Adults in the 2005-2016 National Ambulatory Medical Care Survey.
Jiha LeeChiang-Hua ChangRaymond YungJulie P W BynumPublished in: ACR open rheumatology (2022)
DMARD use for older adults with RA remains low from both rheumatologists and PCPs, including biologic DMARDs, even though American College of Rheumatology guidelines recommend earlier and more aggressive treatment of RA. With predicted shortages in the rheumatology workforce and maldistribution of rheumatology providers, PCPs may play an increasingly important role in caring for older adults with RA. Further research is needed to understand to optimize appropriate use of DMARDs in older patients with RA.
Keyphrases
- rheumatoid arthritis
- disease activity
- rheumatoid arthritis patients
- juvenile idiopathic arthritis
- community dwelling
- ankylosing spondylitis
- middle aged
- physical activity
- interstitial lung disease
- primary care
- blood pressure
- public health
- systemic lupus erythematosus
- quality improvement
- cross sectional
- combination therapy
- smoking cessation